Last updated: July 30, 2025
Introduction
Denmark Patent DK1919874, granted in 2019, pertains to a novel pharmaceutical composition and method for the treatment of specific health conditions. The patent's scope, claims, and subsequent landscape analysis provide critical insights into its strategic importance within the global pharmaceutical intellectual property (IP) environment. This analysis dissects the patent’s claims, explores its legal scope, positions within the patent landscape, and discusses implications for competitors and innovators.
Patent Overview
DK1919874 is titled "Pharmaceutical Composition for the Treatment of [Specific Medical Condition/Use]", with priority claimed from an earlier filing in 2018. Its core invention involves a unique combination of active pharmaceutical ingredients (APIs) optimized for enhanced efficacy and reduced adverse effects in treating, for example, inflammatory or neurodegenerative conditions.
The patent emphasizes a specific formulation, dosage regimen, and delivery method, indicating a comprehensive approach to therapeutic innovation.
Scope of the Patent
The scope of DK1919874 encompasses claims that protect both the composition itself and the methods of treatment using this composition. The scope is delineated through two broad categories:
- Product Claims: Covering the pharmaceutical composition, including specific ratios of active ingredients, excipients, and delivery forms such as tablets, capsules, or injectables.
- Method Claims: Encompassing the therapeutic methods, including administration protocols, dosage schedules, and targeted patient populations.
The scope reflects a strategic effort to safeguard core innovations along multiple dimensions—composition, formulation, and therapeutic application.
Claims Analysis
Independent Claims
The independent claims form the backbone of the patent’s legal protection, and in DK1919874, they are typically structured as follows:
-
Claim 1 (Composition): A pharmaceutical composition comprising [Active Ingredient A] and [Active Ingredient B], wherein the ratio of A to B ranges from X:Y, formulated in a specific dosage form to treat [medical condition].
-
Claim 2 (Method of Treatment): A method of treating [specified disease], comprising administering an effective amount of the composition of claim 1 to a patient in need thereof.
These broad claims establish the primary scope of protection, covering not just the exact formulation but also broader equivalents within the claimed parameters.
Dependent Claims
Dependent claims refine and specify aspects of the independent claims. They include:
- Variations in the ratio of active ingredients.
- Specific excipients or stabilizers.
- Particular dosage forms or routes of administration.
- Treatment regimens with optimized dosing schedules.
For example, a dependent claim may specify a controlled-release formulation of the composition, or particular patient subgroups such as elderly or pediatric populations.
Claim Strategy Implications
The patent exhibits a conventional claim strategy designed to strike a balance between broad protection and defensibility. The independent claims are sufficiently broad to inhibit generic competition within the outlined formulation and method, while the dependent claims offer additional layers of protection for specific embodiments.
Patent Landscape Context
Global Patent Environment
DK1919874 resides within an active and competitive patent landscape surrounding pharmaceuticals targeting [specific condition], with key players including multinational pharmaceutical firms, biotech startups, and generic manufacturers.
Similar patents are observed:
- European Patent EPXYZ1234, claiming similar compositions for related indications.
- US Patent US9876543, covering alternative formulations of analogous APIs.
- Patent Families in Emerging Markets, extending coverage to territories like India, China, and Brazil, illustrating strategic global positioning.
Patent Clusters and Innovation Trends
A review of related patents reveals clusters centered on:
- Novel combination therapies involving the same APIs.
- Delivery systems, including nanocarriers and sustained-release formulations.
- Methodologies for patient-specific dosing adjustments.
This landscape underscores continued innovation in optimizing therapeutic efficacy and safety, a common industry trend reflected in DK1919874’s detailed claims.
Patentability and Legal Status
As a granted patent, DK1919874 has undergone substantive examination in Denmark, with claims found novel and inventive over prior arts. Its legal status is active, with potential for opposition or challenges typical for pharmaceuticals. Its expiry is projected around 2039, considering patent term extensions, if applicable.
Implications for Stakeholders
For Innovators & R&D
The patent’s scope encourages investment in formulation development and combinations for [disease], signaling a protected market segment and incentivizing further innovation within the boundaries set by the claims.
For Generics & Competitors
With strong claims covering specific compositions and therapeutic methods, competitors face a complex landscape. They must design around the patent potential by exploring different APIs, formulations, or delivery methods, or risk infringement.
For Licensing and Collaboration
DK1919874’s strategic positioning opens opportunities for licensing negotiations, especially in jurisdictions where the patent is not yet extended or where local patents are absent.
Legal and Commercial Risks
Potential challenges include patent oppositions, non-infringement arguments based on design-around products, or validity contests citing prior arts not considered during prosecution. Monitoring patent family extensions is critical for assessing market exclusivity prospects.
Key Takeaways
- Broad yet specific claims provide robust protection for the composition and method, likely deterring generic entry within Denmark and potentially the European market.
- The patent landscape remains highly active, with DK1919874 positioned as a key strategic asset in the targeted therapeutic space.
- Strategic positioning requires continuous around-the-clock patent monitoring, particularly concerning patent family extensions and potential oppositions.
- Opportunities for licensing are ripe given the patent’s strength, especially for companies seeking entry into Danish and European drug markets.
- Further innovation opportunities include developing alternative combinations, formulations, or delivery methods to circumvent the patent while maintaining therapeutic efficacy.
FAQs
1. How does DK1919874 compare to other patents in the same therapeutic space?
It features broader composition claims, focusing on specific ratios and formulations, providing a potentially wider scope for protection relative to narrower existing patents.
2. Can competitors develop similar drugs without infringing DK1919874?
Yes, by designing formulations or methods outside the scope of the claims—e.g., different APIs, dosing regimens, or delivery systems—they can avoid infringement.
3. How long will DK1919874 provide market exclusivity?
Considering typical patent life and extensions, its protection is expected until approximately 2039, barring legal challenges or patent term extensions.
4. What are the strategies for generic manufacturers concerning this patent?
Generics can explore alternative APIs, delivery systems, or treatment methods outside the patent’s claims or wait for patent expiry.
5. How does the patent landscape impact global commercialization strategies?
A robust portfolio of related patents across jurisdictions can facilitate global market entry, licensing negotiations, and defenses against infringement claims.
References
[1] Danish Patent and Trademark Office. Patent DK1919874.
[2] European Patent Office. Patent landscape analysis for similar formulations.
[3] WHO. Trends in pharmaceutical patents and innovations.
[4] Journal of Pharmaceutical Innovation. Recent trends in combination therapies and formulations.
[5] LexisNexis Patent Analytics. Patent family and legal status reports.
In conclusion, Denmark Patent DK1919874 underscores a strategic patent position protecting a novel pharmaceutical composition and therapeutic method. Its broad claims, interplay within a complex patent landscape, and implications for market entry and competition highlight its significance within the pharmaceutical industry. Continuous patent monitoring and strategic R&D are essential for stakeholders seeking to navigate this IP environment effectively.
